ArticleCancers2020

HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses.

Jih-Chin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.